000027991 000__ 05142cam\a22007695i\4500
000027991 001__ 27991
000027991 003__ SzGeWIPO
000027991 005__ 20210318105114.0
000027991 006__ m\\\\eo\\d\\\\\\\\
000027991 007__ cr bn |||m|||a
000027991 008__ 170920s2017    gw |||| ob   |00| 0|eng  
000027991 020__ $$a9783319558127
000027991 020__ $$z9783319558134$$qelectronic book
000027991 020__ $$z3319558137$$qelectronic book
000027991 020__ $$z3319558129
000027991 035__ $$a(wipo)011076751
000027991 035__ $$a(OCoLC)1160964621
000027991 040__ $$aSpringer-MARC$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000027991 072_7 $$aE65129$$2E65-201711
000027991 072_7 $$aUPHZHEBO$$2UPHZH-201711
000027991 072_7 $$a172$$2E01-20180112
000027991 08204 $$a344.04233$$223
000027991 084__ $$aN 235 KOB.A$$223
000027991 1001_ $$aKobel, Pierre,$$eauthor.
000027991 24510 $$aAntitrust in pharmaceutical markets & geographical rules of origin /$$cPierre Kobel, Pranvera Këllezi, Bruce Kilpatrick, editors.
000027991 264_1 $$aCham, Switzerland :$$bSpringer,$$c[2017]
000027991 300__ $$a1 online resource (xv, 497 pages).
000027991 336__ $$atext$$2rdacontent
000027991 337__ $$acomputer$$2rdamedia
000027991 338__ $$aonline resource$$bcr$$2rdacarrier
000027991 347__ $$atext file$$bPDF$$2rda
000027991 4901_ $$aLIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition
000027991 5050_ $$aPreface; Contents; List of Contributors; Abbreviations; Part I: Antitrust in Pharmaceutical Markets; 1: International Report; 1.1 Introduction and Summary; 1.1.1 Scope to Differentiate Pharmaceutical Cases as a Matter of Law; 1.1.2 Enforcement Patterns and Consumer Protection in Pharmaceutical Cases; 1.1.3 Innovation and Competition Nexus; 1.1.4 Public Finance and Other Considerations; 1.2 Summary of Questionnaire Responses; 1.2.1 Legal Differentiation of Pharmaceutical Cases in Competition Law; 1.2.1.1 Differences in Underlying Legal Standards; 1.2.1.2 Market Definition.
000027991 520__ $$aThis book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property. The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law. The second part of the book gathers contributions from various jurisdictions on the topic of "What rules should govern claims by suppliers about the national or geographic origin of their goods or services?" This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things. The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues.
000027991 650_0 $$aDrugs$$xAdministration$$xLaw and legislation.
000027991 650_0 $$aPharmacy$$xLaw and legislation.
000027991 650_0 $$aAntitrust law.
000027991 650_0 $$aIntellectual property.
000027991 650_0 $$aCompetition, Unfair.
000027991 650_0 $$aPatent medicines$$xLaw and legislation.
000027991 650_0 $$aMarks of origin$$xLaw and legislation.
000027991 650_0 $$aPharmacology.
000027991 650_0 $$aConflict of laws.
000027991 650_0 $$aInternational law.
000027991 650_0 $$aComparative law.
000027991 650_0 $$aMedical laws and legislation.
000027991 650_0 $$aTrade.
000027991 650_4 $$aCARTEL LAW + ANTI-TRUST LAW (COMPETITION LAW)$$9eng$$8347.776%334.753
000027991 650_4 $$aPHARMACEUTICAL INDUSTRY + PHARMACEUTICAL TRADE$$9eng$$8615.012%66.09
000027991 650_4 $$aCOLLECTIONS OF ESSAYS (TYPE OF DOCUMENT)$$9eng$$8(011.4)
000027991 655_7 $$aOnline-Ressource$$2gnd-carrier
000027991 7001_ $$aKellezi, Pranver Herausgeber,$$eeditor.Herausgeber.
000027991 7001_ $$aKobel, Pierre,$$d1961-$$eeditor.
000027991 7001_ $$aKëllezi, Pranvera,$$eeditor.
000027991 7001_ $$aKilpatrick, Bruce,$$eeditor.
000027991 7102_ $$aInternational League Of Competition Law.
000027991 7102_ $$aLigue Internationale Du Droit De La Concurrence.
000027991 830_0 $$aLIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition.
000027991 8524_ $$bE01$$cEL$$pEBEST2624664
000027991 8524_ $$bE65$$cE65O1$$pEBEST2630343
000027991 8520_ $$bUZZZZ$$pB2491841
000027991 8520_ $$bUPHZH$$cULONL$$pB2493294
000027991 8564_ $$uhttp://sfx.ethz.ch/sfx_locater?sid=ALEPH:EBI01&genre=book&isbn=9783319558134$$zOnline via SFX
000027991 940__ $$d60$$fE65$$gE65O1
000027991 942__ $$cMON$$2ddc
000027991 952__ $$w2018-01-24$$p2018-0002$$u42327$$bMAIN$$10$$kN 235 KOB.A$$v2018-01-24$$zTagged$$70$$yMON
000027991 980__ $$aBIB
000027991 999__ $$c30695$$d30695